Antibiotics with antibiofilm activity - rifampicin and beyond

Area of Science:

• Orthopedics
• Infectious Diseases
• Pharmacology

Background:

• Prosthetic joint infections (PJIs) present complex management challenges.
• Bacterial biofilm formation on foreign materials impedes antibiotic efficacy.
• Antimicrobial resistance and treatment tolerance complicate PJI therapy.

Purpose of the Study:

• To review current strategies for managing PJIs, focusing on antibiofilm activity.
• To highlight effective antibiofilm agents and explore alternative treatment regimens.
• To address the need for potent and diverse antimicrobial options against biofilm.

Main Methods:

• Literature review of studies on prosthetic joint infections and biofilm management.
• Analysis of evidence for drugs with antibiofilm activity.
• Discussion of alternative therapeutic approaches beyond classical regimens.

Main Results:

• Bacterial biofilm significantly complicates PJI treatment by creating a protective matrix.
• Several antimicrobial agents demonstrate antibiofilm activity, though optimal use requires definition.
• Antimicrobial resistance necessitates exploration of diverse and potent therapeutic options.

Conclusions:

• Effective PJI management requires robust antibiofilm strategies.
• Potent and diverse antimicrobial agents are crucial to overcome biofilm challenges.
• Alternative treatment regimens should be considered alongside established guidelines.